We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$2.7B
AUM Growth
-$139M
Cap. Flow
+$52.8M
Cap. Flow %
1.96%
Top 10 Hldgs %
36.19%
Holding
156
New
11
Increased
63
Reduced
61
Closed
10

Top Sells

1
SNPS icon
Synopsys
SNPS
+$23.1M
2
AVGO icon
Broadcom
AVGO
+$13.3M
3
CB icon
Chubb
CB
+$13.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.1M
5
NFLX icon
Netflix
NFLX
+$12.2M

Sector Composition

1 Technology 23.6%
2 Healthcare 16.33%
3 Consumer Discretionary 15.05%
4 Communication Services 12.4%
5 Industrials 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
26
Royalty Pharma
RPRX
$25.8B
$27.4M 1.01%
570,577
+268,954
+89% +$11.8M
DE icon
27
Deere & Co
DE
$161B
$26.7M 0.99%
47,383
+7,675
+19% +$4.33M
LIN icon
28
Linde
LIN
$237B
$26.7M 0.99%
53,815
+2,227
+4% +$1.05M
AAPL icon
29
Apple
AAPL
$4.9T
$26.1M 0.97%
102,816
-3,034
-3% -$790K
MU icon
30
Micron Technology
MU
$959B
$25.9M 0.96%
76,550
-14,710
-16% -$5.76M
APH icon
31
Amphenol
APH
$186B
$24M 0.89%
189,976
+133,935
+239% +$18.9M
MA icon
32
Mastercard
MA
$480B
$23.9M 0.89%
47,805
-1,110
-2% -$585K
RYAAY icon
33
Ryanair
RYAAY
$32.5B
$23.3M 0.86%
403,274
+20,110
+5% +$1.33M
C icon
34
Citigroup
C
$217B
$23.3M 0.86%
205,069
-7,365
-3% -$839K
ONC
35
BeOne Medicines Ltd
ONC
$32.4B
$22.7M 0.84%
76,515
+8,793
+13% +$2.85M
HEI icon
36
HEICO Corp
HEI
$47.9B
$22.7M 0.84%
82,693
+30,224
+58% +$9.73M
TMO icon
37
Thermo Fisher Scientific
TMO
$198B
$22.6M 0.84%
45,947
-11,981
-21% -$6.5M
FTAI icon
38
FTAI Aviation
FTAI
$21.3B
$22.2M 0.82%
90,765
+10,721
+13% +$2.84M
KLAC icon
39
KLA
KLAC
$278B
$21.5M 0.8%
146,080
-1,190
-0.8% -$174K
DB icon
40
Deutsche Bank
DB
$67.3B
$20M 0.74%
685,268
-106,121
-13% -$3.74M
ASML icon
41
ASML
ASML
$671B
$18.8M 0.7%
14,260
-5,207
-27% -$7.14M
TCOM icon
42
Trip.com Group
TCOM
$26.7B
$18M 0.67%
361,726
-9,651
-3% -$563K
CB icon
43
Chubb
CB
$137B
$17.6M 0.65%
54,009
-41,381
-43% -$13.3M
AJG icon
44
Arthur J. Gallagher & Co
AJG
$65.2B
$17.3M 0.64%
79,967
-1,040
-1% -$240K
CVE icon
45
Cenovus Energy
CVE
$52.1B
$17.2M 0.64%
646,538
-82,810
-11% -$1.77M
AEM icon
46
Agnico Eagle Mines
AEM
$68.5B
$16.8M 0.62%
82,997
+8,155
+11% +$1.7M
SHW icon
47
Sherwin-Williams
SHW
$81.7B
$16.8M 0.62%
52,321
-11,398
-18% -$3.92M
JPM icon
48
JPMorgan Chase
JPM
$907B
$16.4M 0.61%
55,626
-19,444
-26% -$5.9M
LHX icon
49
L3Harris
LHX
$52.5B
$15.8M 0.58%
45,712
+8,068
+21% +$2.82M
BG icon
50
Bunge Global
BG
$23.1B
$15.4M 0.57%
120,758
+318
+0.3% +$36.9K

Similar funds

Capital International's Q1 2026 Portfolio in Review

As of Q1 2026, Capital International held 156 positions worth $2.7B, down 4.9% from $2.84B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capital International's Q1 2026 filing shows 11 new, 63 increased, 61 reduced and 10 closed positions. Its largest new stake was AstraZeneca: 472,311 shares worth $92.3M. The largest sale was Synopsys, an estimated $23.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital International's largest Q1 2026 buy was AstraZeneca: 472,311 shares worth $92.3M.
  • Capital International added most to NVIDIA in Q1 2026, an estimated $21.1M increase.
  • Capital International's biggest Q1 2026 reduction was Broadcom, cutting an estimated $13.3M.
  • Capital International fully exited Synopsys in Q1 2026, selling an estimated $23.1M.
  • Capital International's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Capital International opened 11 new positions and closed 10 in Q1 2026.
  • Capital International's portfolio value fell 4.9% quarter-over-quarter to $2.7B.

Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.